Schizophrenia Global Clinical Trials Review, H2, 2011Published:October 2011No. of Pages:135Price:$1000Schizophrenia Global...
Table of ContentsTable of Contents 2List of Tables 5List of Figures 6Introduction 8Schizophrenia 8Report Guidance 8Clinica...
North Suffolk Mental Health Association 74Clinical Trial Overview of North Suffolk Mental Health Association 74Abbott Labo...
Bispebjerg Hospital 102Clinical Trial Overview of Bispebjerg Hospital 102Seoul National University Hospital 103Clinical Tr...
Upcoming SlideShare
Loading in...5
×

Schizophrenia global clinical trials review

385

Published on

GlobalData’s “Schizophrenia Global Clinical Trials Review, H2, 2011” is now available at Marketreportsonline.com.

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
385
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
5
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Schizophrenia global clinical trials review

  1. 1. Schizophrenia Global Clinical Trials Review, H2, 2011Published:October 2011No. of Pages:135Price:$1000Schizophrenia Global Clinical Trials Review, H2, 2011SummaryGlobalDatas clinical trial report, “Schizophrenia Global Clinical Trials Review, H2,2011" provides data on the Schizophrenia clinical trial scenario. This report provideselemental information and data relating to the clinical trials on Schizophrenia. Itincludes an overview of the trial numbers and their recruitment status as per the site oftrial conduction across the globe. The databook offers a preliminary coverage of diseaseclinical trials by their phase, trial status, prominence of the sponsors and also providesbriefing pertaining to the number of trials for the key drugs for Schizophreniatreatment. This report is built using data and information sourced from proprietarydatabases, primary and secondary research and in-house analysis by GlobalDatas teamof industry experts.Note: Certain sections in the report may be removed or altered based on the availabilityand relevance of data for the indicated disease.Scope- Data on the number of clinical trials conducted in North America, South and CentralAmerica, Europe, Middle-East and Africa and Asia-pacific and top five nationalcontributions in each, along with the clinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status, subjects recruitedand sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)Reasons to buy- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment,location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals orCompanies
  2. 2. Table of ContentsTable of Contents 2List of Tables 5List of Figures 6Introduction 8Schizophrenia 8Report Guidance 8Clinical Trials by Region 9Clinical Trials by Country 10Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12Top Five Countries Contributing to Clinical Trials in Europe 13Top Countries Contributing to Clinical Trials in North America 14Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15Top Five Countries Contributing to Clinical Trials in Central and South America 16Clinical Trials by BRIC Nations 17Clinical Trials by G7 Nations 18Clinical Trials in G7 Nations by Trial Status 19Clinical Trials by E7 Nations 20Clinical Trials in E7 Nations by Trial Status 21Clinical Trials by Phase 22In Progress Trials by Phase 23Clinical Trials by Trial Status 24Unaccomplished Trials of Schizophrenia 25Subjects Recruited Over a Period of Time 33Prominent Sponsors 34Top Companies Participating in Schizophrenia Therapeutics Clinical Trials 36Prominent Drug Comparison 38Clinical Trial Profiles 39Clinical Trial Overview of Top Companies 39Johnson & Johnson 39Clinical Trial Overview of Johnson & Johnson 39AstraZeneca PLC 50Clinical Trial Overview of AstraZeneca PLC 50Pfizer Inc. 55Clinical Trial Overview of Pfizer Inc. 55Eli Lilly and Company 60Clinical Trial Overview of Eli Lilly and Company 60Merck & Co., Inc. 64Clinical Trial Overview of Merck & Co., Inc. 64Otsuka Pharmaceutical Co., Ltd. 67Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 67GlaxoSmithKline plc 69Clinical Trial Overview of GlaxoSmithKline plc 69Bristol-Myers Squibb Company 71Clinical Trial Overview of Bristol-Myers Squibb Company 71H. Lundbeck A/S 73Clinical Trial Overview of H. Lundbeck A/S 73
  3. 3. North Suffolk Mental Health Association 74Clinical Trial Overview of North Suffolk Mental Health Association 74Abbott Laboratories 75Clinical Trial Overview of Abbott Laboratories 75Novartis AG 76Clinical Trial Overview of Novartis AG 76Dainippon Sumitomo Pharma Co., Ltd. 77Clinical Trial Overview of Dainippon Sumitomo Pharma Co., Ltd. 77Forest Laboratories, Inc. 78Clinical Trial Overview of Forest Laboratories, Inc. 78F. Hoffmann-La Roche Ltd. 79Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 79Sunovion Pharmaceuticals Inc. 80Clinical Trial Overview of Sunovion Pharmaceuticals Inc. 80Sanofi 81Clinical Trial Overview of Sanofi 81BioLineRx, Ltd. 82Clinical Trial Overview of BioLineRx, Ltd. 82Alexza Pharmaceuticals, Inc. 83Clinical Trial Overview of Alexza Pharmaceuticals, Inc. 83UMC Utrecht 84Clinical Trial Overview of UMC Utrecht 84Clinical Trial Overview of Top Universities / Institutes / Hospitals 85The University of Maryland 85Clinical Trial Overview of The University of Maryland 85Yale University 87Clinical Trial Overview of Yale University 87National Taiwan University Hospital 89Clinical Trial Overview of National Taiwan University Hospital 89National Institute on Drug Abuse 91Clinical Trial Overview of National Institute on Drug Abuse 91Massachusetts General Hospital 93Clinical Trial Overview of Massachusetts General Hospital 93Department of Health 94Clinical Trial Overview of Department of Health 94Sheba Medical Center 96Clinical Trial Overview of Sheba Medical Center 96Centre for Addiction and Mental Health 97Clinical Trial Overview of Centre for Addiction and Mental Health 97Nathan Kline Institute for Psychiatric Research 98Clinical Trial Overview of Nathan Kline Institute for Psychiatric Research 98Vanderbilt University 99Clinical Trial Overview of Vanderbilt University 99University of Pittsburgh 100Clinical Trial Overview of University of Pittsburgh 100The University of North Carolina 101Clinical Trial Overview of The University of North Carolina 101
  4. 4. Bispebjerg Hospital 102Clinical Trial Overview of Bispebjerg Hospital 102Seoul National University Hospital 103Clinical Trial Overview of Seoul National University Hospital 103Shalvata Mental Health Center 104Clinical Trial Overview of Shalvata Mental Health Center 104Dartmouth-Hitchcock Medical Center 105Clinical Trial Overview of Dartmouth-Hitchcock Medical Center 105Beersheva Mental Health Center 106Clinical Trial Overview of Beersheva Mental Health Center 106Manhattan Psychiatric Center 107Clinical Trial Overview of Manhattan Psychiatric Center 107BeerYaakov Mental Health Center 108Clinical Trial Overview of BeerYaakov Mental Health Center 108University of Cologne 109Clinical Trial Overview of University of Cologne 109Five Key Clinical Profiles 110Appendix 131Abbreviations 131Definitions 131Research Methodology 133Secondary Research 133About GlobalData 134Contact Us 134Disclaimer 134Source 135About Us:MarketReportsOnline is comprising of an online library of 50,000 reports, in-depthmarket research studies of over 5000 micro markets, and 25 industry specific websites.We provide 24/7 online and offline support to our customers. Get in touch with us foryour needs of market research reports.Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: + 1 888 391 5441E-mail: sales@marketreportsonline.comhttp://marketreportsonline.com/

×